StemCell Institute Inc. (TYO:7096)
Japan flag Japan · Delayed Price · Currency is JPY
637.00
-3.00 (-0.47%)
Nov 18, 2026, 9:49 AM JST

StemCell Institute Revenue

In the fiscal year ending March 31, 2026, StemCell Institute had annual revenue of 2.81B JPY with 4.93% growth. StemCell Institute had revenue of 671.00M in the quarter ending September 30, 2026, a decrease of -6.15%. That makes StemCell Institute the 34,599th largest company in the world by revenue and 3,543rd in Japan.

Revenue
2.81B
Revenue Growth
+4.93%
P/S Ratio
2.29
Revenue / Employee
24.03M
Employees
117
Market Cap
6.41B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20262.81B132.00M4.93%
Mar 31, 20252.68B198.00M7.98%
Mar 31, 20242.48B390.00M18.65%
Mar 31, 20232.09B310.00M17.41%
Mar 31, 20221.78B372.00M26.40%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.